Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MindBio Therapeutics Corp C.MBIO

MindBio Therapeutics Corp. is a biotech/biopharma company. It creates novel and emerging treatments for mental health conditions and is conducting take-home Microdosing (MB22001) human clinical trials. MB22001 is its lead candidate drug, a titratable form of Lysergic Acid Diethylamide designed for take-home microdosing. It is focused on microdosing of psychedelic medicines and is advancing its drug and technology protocols through clinical trials. It develops a multi-disciplinary platform for developing treatments and is involved in psychedelic medicine development and digital therapeutics, has completed Phase 1 clinical trials in 80 healthy participants and has completed a Phase 2a clinical trial in patients with Major Depressive Disorder. The underway are two Phase 2B trials, one in cancer patients experiencing existential distress and another in patients with Major Depressive Disorder. It invests in research that forms the basis for developing novel and clinically proven treatments.


CSE:MBIO - Post by User

Comment by Smokey1958on May 20, 2024 5:58pm
71 Views
Post# 36049123

RE:RE:RE:Beware the Aussie Bullies

RE:RE:RE:Beware the Aussie Bullies

You might want to (a) read the whole report on sedar (b) consider the conversion of a major loan to shares (as requested by the lender) (c)  understand it's an early stage pharma company which in the words of one of the researchers involved is involved in "research that punches way above their weight" and (d) alternative sources of funding to the researchers, including the following:

* 2021 $249,000 grant for the end of life cancer trials - 42 months

* June 2022 $1.4+ million grant for microdosing LSD and depression - 36 months

* May 2024 $264,233 grant for microdosing LSD and PMS pain/depression - 24 months

P.S. You might also want to look up the agreement between MBIO and the University of Auckland.

Clearly you're not invested in the company ....trying to save us??? Why don't you worry about your own investments ...(serious question) do you have any?

 

<< Previous
Bullboard Posts
Next >>